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Abstract
A 26-year-old woman was referred to an Emergency Department because of common flu-like
syndrome with hemodynamic collapse. In Intensive Care Unit (ICU), she was diagnosed as a
probable septic shock. But despite treatment her condition rapidly deteriorated during the
subsequent hours. Diagnosis of cardiogenic shock was established. Mechanical circulatory support
was inserted into the patient. She was transferred in a Cardio-Vascular Surgical ICU where at the
5th day of mechanical circulatory support, echocardiography showed heart recovery which allowed
weaning of mechanical circulatory support and progressive withdrawal of inotropic support. She
was discharged at the 26th day. During her hospitalization, presence of Influenza A RNA was shown
in myocardial biopsy.
Introduction
Fulminant myocarditis causing severe hemodynamic dys-
function and requiring high-dose vasopressors or
mechanical circulatory support is rare; however, intensive
care unit physicians should be aware that its treatment
may require the use of mobile circulatory support devices.
We report a case of acute fulminant myocarditis caused by
influenza A infection, a rare etiology, successfully treated
by percutaneous extracorporeal membrane oxygenation
(ECMO) with cardio-pulmonary bypass.
Case report
A previously healthy 26-year-old woman was referred to
the Emergency Department with an influenza-like illness,
which had started 2 days previously, and was associated
with progressive disturbance of consciousness. Clinical
examination was normal except for a blood pressure of
70/30 mmHg and a tachycardia of 120 beats/min. There
was no response to a fluid challenge (1 L of colloid over
30 min). Central nervous system infection was ruled out
by lumbar puncture and cerebral tomodensitometry. Her
white blood cell count was 7,000 per μl and the procalci-
tonin concentration was not raised. EKG and chest radiog-
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raphy were normal. The first troponin measurement was
0.02 ng/mL.
The patient was transferred in a medical Intensive Care
Unit (ICU) under the diagnosis of probable septic shock.
Fluid resuscitation (4 L of cristalloids during the 6 first
hours) was followed by a daily continuous infusion of 3 L
of cristalloids and norepinephrine infusion. Antibiotics
were given: cefotaxime (4 × 2 g/day, erythromycin 3 × 1 g/
day and gentamycin 1 × 400 mg/day), plus intravenous
hydrocortisone (200 mg per day).
Fluid resuscitation produced no improvement in blood
pressure. Degradation of the oxygenation (PaO2/FiO2 <
120) requiring mechanical ventilation was observed. Her
hemodynamic status rapidly deteriorated during the sub-
sequent hours despite high doses of vasopressor (nore-
pinephrine 5 mg/h). Diagnosis of cardiogenic shock was
established by the association of severe hemodynamic
compromise requiring high-dose of vasopressor, low right
atrial oxygen saturation (45%) and transthoracic echocar-
diography showing a diffuse hypokinesia with an esti-
mated left ventricular ejection fraction (LVEF) of 20%,
elevated right and left filling pressures. Left ventricle
diastolic dimensions were however normal (44 mm) as
was septal thickness (8 mm). The troponin I concentra-
tion was 28 ng/mL. Monitoring by pulse contour analysis
and thermodilution showed a cardiac index of 2.4 L/min/
m2. Restriction of parenteral fluids and continuous veno-
venous hemofiltration with fluid removal at an average
rate of 300 ml/h substantially improved gas exchange.
However, despite increased inotropic support (epine-
phrine 2 to 25 mg/h and dobutamine 12 μg/kg/min), the
hemodynamic status further worsened and the multi-
organ dysfunction syndrome became obvious (arterial
lactate level at 10 mmol/L, alanine aminotransferase level
of 293 IU/L, aspartate aminotransferase level of 587 IU/L,
bilirubin level of 21 mg/dL and progressive oliguria)
(Table 1).
A circulatory support device was connected by percutane-
ous femoral vein and artery cannulation. Pump flow of
3500 rpm generated an output of 4 L/min and a non pul-
satile systemic pressure of 80 mmHg. Intravenous heparin
was given, aiming at an activated cephalin time of 60–80
secs. This procedure allowed rapid weaning of the ino-
tropic support, and led to urine production and decreased
lactacidemia (Table 1).
The patient was transferred to a Cardiac ICU 24 hours
later. Echocardiography showed lower left and right heart
pressures, but the LVEF was persistently low at 20%. Mul-
tiple biopsies of the myocardium were performed. These
latter, using routine staining, revealed interstitial inflam-
mation and tissue destruction, but bacterial cultures
remained negative. Real time polymerase chain reaction
Table 1: Evolution of hemodynamic data, inotropic support and biology at the admission and during hospitalization in medical ICU
H H+6 H+12 H+18 H+24 H+48
Emergency
department
ICU admission
ventilation
Before CVVHDF Before ECMO Before transfer in 
surgical ICU
Hemodynamic data
MAP (mmHg) 60 66 80 78 55 78 86
Cardiac index (L × min-1 × m-2)4 . 4 3 . 8 2 . 4
LVEF (%) 45 22 11
Urinary output (mL/h) 450 400 33 40 80 100
Inotropic support
Epinephrine (mg/h) 5 25 10 4
Norepinephrine (mg/h) 2.1 4.8 14.4 0
Dobutamine (μg × kg-1 × min-1)8 1 3 1 7
Biology
Troponin I (ng/mL) 0.75 10.10 18.6 29.77 28.36 23.18
BNP (pg/mL)) 228 321 288
pH 7.36 7.16 7.27 7.19 7.13 7.30
Lactate level (mmol/L) 0.7 1.25 1.8 2.83 9.84 13.47 11.69
PaO2/FiO2 120 157 59 225 196 312
ASAT (IU/L)/ALAT (IU/L) 43/18 35/21 28/36 587/293
Total bilirubin (mg/dL) 11 15 21
INR 1.33 1.96 2.35 4.15
Factor V (%) 30% < 20%
ICU: intensive care unit; CVVHDF: continuous veno-venous hemodiafiltration; ECMO: extracorporeal membrane oxygenation; MAP: mean arterial 
pressure; LVEF: left ventricle ejection fraction; BNP: brain natriuretic peptide; ASAT: aspartate aminotransferase; ALAT: alanine aminotransferase; 
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showed the presence of Influenza A RNA in the biopsy.
Influenza A infection was confirmed by serologic tests and
positive culture of the endotracheal aspirate. Liver func-
tion tests improved during circulatory support but there
was anuric renal failure. On the 5th day of mechanical cir-
culatory support, echocardiography showed improved
diastolic and systolic function (LVEF of 50%) which
allowed the progressive withdrawal of inotropic support.
Mechanical circulatory support was reduced on the 6th
day, and was withdrawn 24 hours later. The empiric anti-
biotherapy was stopped on the 7th day; she was extubated
on the 13th, and vasopressor support was withdrawn on
the 15th. Renal function recovered after 20 days of contin-
uous veno-venous hemofiltration. She was discharged on
the 26th day with an LVEF of 70%, good diastolic function
and no ventricular dilatation.
Discussion
Myocarditis is an inflammation of the myocardium
caused by viral, bacterial or protozoal infections, drug tox-
icity or immunological reactions. Viral myocarditis
remains the prototype for the study of this disease and its
evolution. Nevertheless few cases of Influenza-associated
myocarditis have been reported [1-6].
The diagnosis of myocarditis may be difficult to make in
the early stages of the disease. In this case, it was initially
misdiagnosed as septic shock, in which myocardial dys-
function and mild troponin increase are commonly seen.
This case report underlines the role of echocardiography
for diagnosis and management of myocarditis [7]. Left
ventricular dysfunction is the most common abnormality
reported during myocarditis but is unspecific. An increase
in brightness, heterogeneity and contrast of the myocar-
dium may suggest myocarditis. Furthermore, fulminant
myocarditis could be distinguished from acute myocardi-
tis by echocardiographic criteria. Patients with fulminant
myocarditis typically have near-normal left ventricle
diastolic dimensions with increased septal thickness at
presentation, whereas those with acute myocarditis have
increased diastolic dimensions but normal septal thick-
ness [7]. However, in this case report, septal thickness was
normal. Endomyocardial biopsy is still considered by
many to be the gold standard for diagnosing myocarditis.
Drawbacks are that the results are delayed, and even if
diagnosis is confirmed or an etiologic agent identified, no
specific treatment recommendations for myocarditis can
be made. Indeed, influenza antiviral agents like amanta-
dine, rimadantine or neuraminidase inhibitors have not
been tested in influenza-associated myocarditis and
immune modulatory therapies have not proved them-
selves in controlled trials [8].
The treatment thus remains supportive. Intensive care
physicians suspecting fulminant myocarditis must be pre-
pared to use therapeutic options such as circulatory sup-
port before severe organ failure develops. Usually heart
transplantation is delayed for weeks. This strategy is
strongly supported by the fact that fulminant myocarditis
are commonly reversible within a few days and have a bet-
ter long-term prognosis than acute myocarditis [8].
Circulatory support is used to maintain cardiac output
and organ perfusion, and to minimize the need for ino-
tropic support until myocardial recovery. Alternatively it
can be a bridge to long-term assist devices or heart trans-
plantation. We choose a non-pulsatile, servo-regulated
flow system driven by a centrifugal pump with a mem-
brane oxygenator. It is relatively inexpensive, and can be
set up within 30 min by percutaneous cannulation of the
femoral vessels at the bedside, and can take over the func-
tion of both heart and lungs. Non-pulsatile blood flow is
adequate for short term circulatory support (2–3 weeks)
[9]. Organ dysfunction can be prevented by setting a flow
rate sufficient to normalize indicators of circulatory fail-
ure such as pH, lactate, and SVO2 [9]. Left ventricular
preload must be optimized and third space fluid reduced
by normalizing oncotic pressure, avoiding excessive vol-
ume loading and using hemofiltration. It is essential to
maintain sinus rhythm and to preserve left ventricular
contractility with inotropic support, to prevent secondary
myocardial damage and thrombotic complication
induced by blood stagnation, even if systemic perfusion is
maintained. Protective mechanical ventilation is main-
tained to oxygenate any blood delivered to the pulmonary
vascular bed by residual myocardial activity, and to avoid
atelectasis [10].
Complications associated with these devices are frequent.
Then, even if these devices can be set up in an emergency
unit, their routine management remains the role of spe-
cialized units. Furthermore, the decision to switch to a
pulsatile paracorporeal or implantable systems allowing
extended periods of support, or to proceed with heart
transplantation before complications of long term extra-
corporeal circulatory support occur, remains one for expe-
rienced clinicians.
Conclusion
The diagnosis of fulminant myocarditis may be difficult in
the intensive care unit and identification of the viral agent
is uncommon. Echocardiography is invaluable when the
hemodynamic status worsens despite normally adequate
treatment. A human outbreak of avian Influenza A H5N1
could see many cases of influenza-associated myocarditis
and thus intensive care unit physicians should be aware of
the possibilities of mobile closed chest cardiopulmonary
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